Artiva Biotherapeutics, Inc. ARTV Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$23.52M-13.2% | -$20.77M+3.5% | -$21.53M-1.3% | -$21.25M-4.6% | -$20.31M-26.2% | ||
| $666K0.0% | $666K+0.6% | $662K+3.3% | $641K+2.1% | $628K+2.3% | ||
| $1.59M+0.3% | $1.59M-2.6% | $1.63M+5.3% | $1.55M-24.5% | $2.05M-6.0% | ||
| -$20.95M-42.3% | -$14.73M+23.3% | -$19.2M+16.5% | -$22.98M-15.8% | -$19.84M-35.4% | ||
| $242K-42.5% | $421K-29.8% | $600K-43.1% | $1.06M+106% | $511K+698% | ||
| $15.32M-4.5% | $16.04M-1.5% | $16.28M-22.9% | $21.12M+112% | $9.97M+1,132% | ||
| -$112K— | —— | —— | —— | $239K— | ||
| -$5.75M— | $0+100% | -$2.96M-53.1% | -$1.93M+79.9% | -$9.63M+38.4% | ||
| -$21.19M-39.9% | -$15.15M+23.5% | -$19.8M+17.6% | -$24.04M-18.1% | -$20.35M-38.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Artiva Biotherapeutics, Inc. generate?
- Artiva Biotherapeutics, Inc. (ARTV) generated -$77.9M in operating cash flow over the trailing twelve months.
- What is Artiva Biotherapeutics, Inc.'s free cash flow?
- After $2.3M of capital expenditures, Artiva Biotherapeutics, Inc.'s free cash flow was -$80.2M over the trailing twelve months, down 31.6% year over year.
- Where does Artiva Biotherapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Artiva Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.